ArticleExperimental and therapeutic medicine2021

Apatinib inhibits gastric carcinoma development by regulating the expression levels of IL-17 via the Bax/Bcl-2 signaling pathway.

Tianxi Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.